| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | xylose binding | 2.95e-05 | 2 | 109 | 2 | GO:0033222 | |
| GeneOntologyBiologicalProcess | extrathymic T cell selection | 1.32e-07 | 3 | 106 | 3 | GO:0045062 | |
| GeneOntologyBiologicalProcess | extrathymic T cell differentiation | 1.31e-06 | 5 | 106 | 3 | GO:0033078 | |
| MousePheno | abnormal CD4-positive, gamma-delta intraepithelial T cell morphology | 3.48e-05 | 2 | 83 | 2 | MP:0008357 | |
| MousePheno | decreased CD4-positive, gamma-delta intraepithelial T cell number | 3.48e-05 | 2 | 83 | 2 | MP:0008359 | |
| MousePheno | decreased gamma-delta intraepithelial T cell number | 7.01e-05 | 14 | 83 | 3 | MP:0008351 | |
| MousePheno | abnormal gamma-delta intraepithelial T cell morphology | 1.07e-04 | 16 | 83 | 3 | MP:0008349 | |
| MousePheno | decreased mature gamma-delta T cell number | 1.29e-04 | 17 | 83 | 3 | MP:0008354 | |
| MousePheno | abnormal intraepithelial T cell number | 1.54e-04 | 18 | 83 | 3 | MP:0008895 | |
| MousePheno | decreased gamma-delta T cell number | 1.70e-04 | 47 | 83 | 4 | MP:0008347 | |
| Domain | Glc_transpt_3 | 3.25e-05 | 2 | 107 | 2 | IPR002945 | |
| Domain | Ig-like_fold | MPL FLNC MYCBP2 BTNL8 PKHD1L1 LY6G6F CD8A PTPRH BTNL3 PLXNC1 SIGIRR KIRREL1 ASTN1 IL2RB | 5.04e-05 | 706 | 107 | 14 | IPR013783 |
| Domain | - | MPL FLNC MYCBP2 BTNL8 PKHD1L1 LY6G6F CD8A BTNL3 PLXNC1 SIGIRR KIRREL1 ASTN1 IL2RB | 1.07e-04 | 663 | 107 | 13 | 2.60.40.10 |
| Domain | PRY | 1.63e-04 | 48 | 107 | 4 | SM00589 | |
| Domain | PRY | 1.63e-04 | 48 | 107 | 4 | IPR006574 | |
| Domain | Quinoprotein_ADH-like_supfam | 2.40e-04 | 53 | 107 | 4 | IPR011047 | |
| Domain | ConA-like_dom | 2.68e-04 | 219 | 107 | 7 | IPR013320 | |
| Domain | WD40_repeat_CS | 3.64e-04 | 164 | 107 | 6 | IPR019775 | |
| Domain | - | 6.62e-04 | 333 | 107 | 8 | 2.130.10.10 | |
| Domain | APC_su10/DOC_dom | 6.70e-04 | 7 | 107 | 2 | IPR004939 | |
| Domain | DOC | 6.70e-04 | 7 | 107 | 2 | PS51284 | |
| Domain | APC10 | 6.70e-04 | 7 | 107 | 2 | SM01337 | |
| Domain | ANAPC10 | 6.70e-04 | 7 | 107 | 2 | PF03256 | |
| Domain | WD40/YVTN_repeat-like_dom | 6.89e-04 | 335 | 107 | 8 | IPR015943 | |
| Domain | Butyrophylin | 6.98e-04 | 70 | 107 | 4 | IPR003879 | |
| Domain | WD40 | 7.30e-04 | 259 | 107 | 7 | PF00400 | |
| Domain | Sugar_transporter_CS | 8.03e-04 | 32 | 107 | 3 | IPR005829 | |
| Domain | - | 8.18e-04 | 73 | 107 | 4 | 2.60.120.260 | |
| Domain | WD40 | 8.91e-04 | 268 | 107 | 7 | SM00320 | |
| Domain | WD40_repeat | 9.72e-04 | 272 | 107 | 7 | IPR001680 | |
| Domain | WD_REPEATS_1 | 1.10e-03 | 278 | 107 | 7 | PS00678 | |
| Domain | WD_REPEATS_2 | 1.13e-03 | 279 | 107 | 7 | PS50082 | |
| Domain | WD_REPEATS_REGION | 1.13e-03 | 279 | 107 | 7 | PS50294 | |
| Domain | MFS_sugar_transport-like | 1.14e-03 | 36 | 107 | 3 | IPR005828 | |
| Domain | Sugar_tr | 1.14e-03 | 36 | 107 | 3 | PF00083 | |
| Domain | LAM_G_DOMAIN | 1.33e-03 | 38 | 107 | 3 | PS50025 | |
| Domain | Laminin_G_2 | 1.55e-03 | 40 | 107 | 3 | PF02210 | |
| Domain | SPRY | 1.57e-03 | 87 | 107 | 4 | SM00449 | |
| Domain | WD40_repeat_dom | 1.61e-03 | 297 | 107 | 7 | IPR017986 | |
| Domain | Filamin | 1.73e-03 | 11 | 107 | 2 | PF00630 | |
| Domain | GAIN_dom_N | 1.73e-03 | 11 | 107 | 2 | IPR032471 | |
| Domain | FILAMIN_REPEAT | 1.73e-03 | 11 | 107 | 2 | PS50194 | |
| Domain | Filamin/ABP280_rpt | 1.73e-03 | 11 | 107 | 2 | IPR001298 | |
| Domain | GAIN | 1.73e-03 | 11 | 107 | 2 | PF16489 | |
| Domain | Filamin/ABP280_repeat-like | 1.73e-03 | 11 | 107 | 2 | IPR017868 | |
| Domain | TRYPSIN_SER | 1.78e-03 | 90 | 107 | 4 | IPR033116 | |
| Domain | PRY | 1.78e-03 | 42 | 107 | 3 | PF13765 | |
| Domain | LamG | 2.04e-03 | 44 | 107 | 3 | SM00282 | |
| Domain | Quinoprot_gluc/sorb_DH | 2.07e-03 | 12 | 107 | 2 | IPR011041 | |
| Domain | SPRY | 2.09e-03 | 94 | 107 | 4 | PF00622 | |
| Domain | SPRY_dom | 2.09e-03 | 94 | 107 | 4 | IPR003877 | |
| Domain | Galactose-bd-like | 2.09e-03 | 94 | 107 | 4 | IPR008979 | |
| Domain | B30.2/SPRY | 2.17e-03 | 95 | 107 | 4 | IPR001870 | |
| Domain | B302_SPRY | 2.17e-03 | 95 | 107 | 4 | PS50188 | |
| Domain | CUB | 2.78e-03 | 49 | 107 | 3 | PF00431 | |
| Domain | Sugar/inositol_transpt | 2.83e-03 | 14 | 107 | 2 | IPR003663 | |
| Domain | TRYPSIN_HIS | 2.91e-03 | 103 | 107 | 4 | IPR018114 | |
| Domain | G_PROTEIN_RECEP_F2_2 | 2.95e-03 | 50 | 107 | 3 | PS00650 | |
| Domain | 7tm_2 | 2.95e-03 | 50 | 107 | 3 | PF00002 | |
| Domain | CUB | 2.95e-03 | 50 | 107 | 3 | SM00042 | |
| Domain | Ig_E-set | 3.02e-03 | 104 | 107 | 4 | IPR014756 | |
| Domain | TRYPSIN_SER | 3.23e-03 | 106 | 107 | 4 | PS00135 | |
| Domain | N2O_reductase_N | 3.25e-03 | 15 | 107 | 2 | IPR011045 | |
| Domain | - | 3.30e-03 | 52 | 107 | 3 | 2.60.120.290 | |
| Domain | TRYPSIN_HIS | 3.34e-03 | 107 | 107 | 4 | PS00134 | |
| Domain | CUB | 3.48e-03 | 53 | 107 | 3 | PS01180 | |
| Domain | Peptidase_S1A | 4.06e-03 | 113 | 107 | 4 | IPR001314 | |
| Domain | V-set | 4.16e-03 | 184 | 107 | 5 | PF07686 | |
| Domain | SUGAR_TRANSPORT_2 | 4.18e-03 | 17 | 107 | 2 | PS00217 | |
| Domain | FN3 | 4.25e-03 | 185 | 107 | 5 | SM00060 | |
| Domain | CUB_dom | 4.27e-03 | 57 | 107 | 3 | IPR000859 | |
| Domain | TRYPSIN_DOM | 4.33e-03 | 115 | 107 | 4 | PS50240 | |
| Domain | Laminin_G | 4.49e-03 | 58 | 107 | 3 | IPR001791 | |
| Domain | Tryp_SPc | 4.60e-03 | 117 | 107 | 4 | SM00020 | |
| Domain | GPCR_2_secretin-like | 4.94e-03 | 60 | 107 | 3 | IPR000832 | |
| Domain | GPCR_2-like | 4.94e-03 | 60 | 107 | 3 | IPR017981 | |
| Domain | G_PROTEIN_RECEP_F2_4 | 5.17e-03 | 61 | 107 | 3 | PS50261 | |
| Domain | Trypsin | 5.18e-03 | 121 | 107 | 4 | PF00089 | |
| Domain | Trypsin_dom | 5.18e-03 | 121 | 107 | 4 | IPR001254 | |
| Domain | Peptidase_S1_PA | 5.49e-03 | 123 | 107 | 4 | IPR009003 | |
| Pubmed | An intense form of homeostatic proliferation of naive CD8+ cells driven by IL-2. | 6.11e-07 | 6 | 110 | 3 | 17664294 | |
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 23615220 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 28324109 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 21368163 | ||
| Pubmed | Expression of the brain-type glucose transporter is restricted to brain and neuronal cells in mice. | 9.91e-06 | 2 | 110 | 2 | 1516757 | |
| Pubmed | Glucose Transporter 3 Potentiates Degranulation and Is Required for Platelet Activation. | 9.91e-06 | 2 | 110 | 2 | 28663252 | |
| Pubmed | A butyrophilin family member critically inhibits T cell activation. | 9.91e-06 | 2 | 110 | 2 | 20944003 | |
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 19506559 | ||
| Pubmed | The ontogeny of Butyrophilin-like (Btnl) 1 and Btnl6 in murine small intestine. | 9.91e-06 | 2 | 110 | 2 | 27528202 | |
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 25892112 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 33368883 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 37636066 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 11017787 | ||
| Pubmed | Neuronal functions, feeding behavior, and energy balance in Slc2a3+/- mice. | 9.91e-06 | 2 | 110 | 2 | 18780771 | |
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 8654954 | ||
| Pubmed | Altered Actions of Memantine and NMDA-Induced Currents in a New Grid2-Deleted Mouse Line. | 9.91e-06 | 2 | 110 | 2 | 25513882 | |
| Pubmed | Expression of mouse-GLUT3 and human-GLUT3 glucose transporter proteins in brain. | 9.91e-06 | 2 | 110 | 2 | 1734877 | |
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 31884568 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 33482226 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 23193055 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 8198523 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 9176231 | ||
| Pubmed | Glucose Transporter 3 is Essential for the Survival of Breast Cancer Cells in the Brain. | 9.91e-06 | 2 | 110 | 2 | 31817208 | |
| Pubmed | Brain glucose transporter (Glut3) haploinsufficiency does not impair mouse brain glucose uptake. | 9.91e-06 | 2 | 110 | 2 | 21316350 | |
| Pubmed | Altered lactate metabolism in Huntington's disease is dependent on GLUT3 expression. | 9.91e-06 | 2 | 110 | 2 | 29582588 | |
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 27703009 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 22700768 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 18445753 | ||
| Pubmed | 1.36e-05 | 15 | 110 | 3 | 17362910 | ||
| Pubmed | Coeliac disease-associated risk variants in TNFAIP3 and REL implicate altered NF-kappaB signalling. | 2.25e-05 | 265 | 110 | 7 | 19240061 | |
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 27573835 | ||
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 25578782 | ||
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 29614685 | ||
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 19050240 | ||
| Pubmed | Utilization of the beta and gamma chains of the IL-2 receptor by the novel cytokine IL-15. | 2.97e-05 | 3 | 110 | 2 | 8026467 | |
| Pubmed | Glucose transporter GLUT3: ontogeny, targeting, and role in the mouse blastocyst. | 2.97e-05 | 3 | 110 | 2 | 9108057 | |
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 21984699 | ||
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 24243341 | ||
| Pubmed | Combined IL-15/IL-15Ralpha immunotherapy maximizes IL-15 activity in vivo. | 2.97e-05 | 3 | 110 | 2 | 17056533 | |
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 1730609 | ||
| Pubmed | Glucose transporter isoform-3 mutations cause early pregnancy loss and fetal growth restriction. | 2.97e-05 | 3 | 110 | 2 | 17213475 | |
| Pubmed | Gestational changes of glucose transporter gene expression in the mouse placenta and decidua. | 2.97e-05 | 3 | 110 | 2 | 8905482 | |
| Pubmed | USP28 controls SREBP2 and the mevalonate pathway to drive tumour growth in squamous cancer. | 2.97e-05 | 3 | 110 | 2 | 37202505 | |
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 31561359 | ||
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 33586490 | ||
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 19550108 | ||
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 38246582 | ||
| Pubmed | Placental glucose transporter expression is regulated by glucocorticoids. | 2.97e-05 | 3 | 110 | 2 | 10199793 | |
| Pubmed | Molecular mechanisms of snoRNA-IL-15 crosstalk in adipocyte lipolysis and NK cell rejuvenation. | 2.97e-05 | 3 | 110 | 2 | 37329887 | |
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 23018461 | ||
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 32375678 | ||
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 7926364 | ||
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 35077394 | ||
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 9070948 | ||
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 19327547 | ||
| Pubmed | Glucose Metabolism Is Required for Platelet Hyperactivation in a Murine Model of Type 1 Diabetes. | 2.97e-05 | 3 | 110 | 2 | 30765335 | |
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 16284400 | ||
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 28746873 | ||
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 3170580 | ||
| Pubmed | 5.92e-05 | 4 | 110 | 2 | 7961103 | ||
| Pubmed | 5.92e-05 | 4 | 110 | 2 | 22383310 | ||
| Pubmed | 5.92e-05 | 4 | 110 | 2 | 23493374 | ||
| Pubmed | 5.92e-05 | 4 | 110 | 2 | 34035344 | ||
| Pubmed | 5.92e-05 | 4 | 110 | 2 | 31882430 | ||
| Pubmed | Mechanistic and structural insight into the functional dichotomy between IL-2 and IL-15. | 5.92e-05 | 4 | 110 | 2 | 23104097 | |
| Pubmed | 5.92e-05 | 4 | 110 | 2 | 15932944 | ||
| Pubmed | Blood natural killer cell deficiency reveals an immunotherapy strategy for atopic dermatitis. | 5.92e-05 | 4 | 110 | 2 | 32102931 | |
| Pubmed | 5.92e-05 | 4 | 110 | 2 | 32724083 | ||
| Pubmed | 5.92e-05 | 4 | 110 | 2 | 28471544 | ||
| Pubmed | 5.92e-05 | 4 | 110 | 2 | 35810171 | ||
| Pubmed | 5.92e-05 | 4 | 110 | 2 | 7653530 | ||
| Pubmed | 5.92e-05 | 4 | 110 | 2 | 22347158 | ||
| Pubmed | Critical role of IL-15-IL-15R for antigen-presenting cell functions in the innate immune response. | 5.92e-05 | 4 | 110 | 2 | 11702064 | |
| Pubmed | 5.92e-05 | 4 | 110 | 2 | 9124334 | ||
| Pubmed | Oxygen-regulated expression of GLUT-1, GLUT-3, and VEGF in the mouse blastocyst. | 5.92e-05 | 4 | 110 | 2 | 15515055 | |
| Pubmed | CD8alphaalpha-mediated survival and differentiation of CD8 memory T cell precursors. | 5.92e-05 | 4 | 110 | 2 | 15105501 | |
| Pubmed | Maternal hyperglycemia alters glucose transport and utilization in mouse preimplantation embryos. | 5.92e-05 | 4 | 110 | 2 | 9688872 | |
| Pubmed | Epithelia Use Butyrophilin-like Molecules to Shape Organ-Specific γδ T Cell Compartments. | 5.92e-05 | 4 | 110 | 2 | 27641500 | |
| Pubmed | Developmental regulation of genes mediating murine brain glucose uptake. | 5.92e-05 | 4 | 110 | 2 | 10070152 | |
| Pubmed | In vitro analysis of the glucose-transport system in GLUT4-null skeletal muscle. | 5.92e-05 | 4 | 110 | 2 | 10455018 | |
| Pubmed | 5.92e-05 | 4 | 110 | 2 | 25526803 | ||
| Pubmed | 5.92e-05 | 4 | 110 | 2 | 23536631 | ||
| Pubmed | 5.92e-05 | 4 | 110 | 2 | 15054091 | ||
| Pubmed | 5.92e-05 | 4 | 110 | 2 | 17983831 | ||
| Pubmed | 5.92e-05 | 4 | 110 | 2 | 26339590 | ||
| Pubmed | 5.92e-05 | 4 | 110 | 2 | 9360952 | ||
| Pubmed | Endotoxin-induced enhancement of glucose influx into murine peritoneal macrophages via GLUT1. | 5.92e-05 | 4 | 110 | 2 | 8557327 | |
| Pubmed | 5.92e-05 | 4 | 110 | 2 | 37721853 | ||
| Pubmed | Glucose uptake, utilization, and signaling in GLUT2-null islets. | 5.92e-05 | 4 | 110 | 2 | 10969832 | |
| Pubmed | 5.92e-05 | 4 | 110 | 2 | 33774619 | ||
| Pubmed | Immunohistochemical localization and quantification of glucose transporters in the mouse brain. | 5.92e-05 | 4 | 110 | 2 | 11955709 | |
| Pubmed | ZXDC ADAMTS4 BTNL8 IL17RC FCSK BTNL3 SIGIRR ADGRE3 C1orf159 BCAR3 CSMD1 PIGO | 6.88e-05 | 985 | 110 | 12 | 12975309 | |
| Pubmed | 9.85e-05 | 5 | 110 | 2 | 29339503 | ||
| Pubmed | 9.85e-05 | 5 | 110 | 2 | 12093160 | ||
| Pubmed | Organization of the mouse microfibril-associated glycoprotein-2 (MAGP-2) gene. | 9.85e-05 | 5 | 110 | 2 | 10723723 | |
| Pubmed | 9.85e-05 | 5 | 110 | 2 | 1638987 | ||
| Pubmed | 9.85e-05 | 5 | 110 | 2 | 7641685 | ||
| Pubmed | 9.85e-05 | 5 | 110 | 2 | 16365304 | ||
| Pubmed | The glucose transporter family: structure, function and tissue-specific expression. | 9.85e-05 | 5 | 110 | 2 | 8240230 | |
| Pubmed | 9.85e-05 | 5 | 110 | 2 | 36862513 | ||
| Cytoband | 4q31 | 2.53e-04 | 10 | 110 | 2 | 4q31 | |
| GeneFamily | WD repeat domain containing | 1.26e-04 | 262 | 77 | 7 | 362 | |
| GeneFamily | Ubiquitin specific peptidases | 1.75e-03 | 56 | 77 | 3 | 366 | |
| GeneFamily | Butyrophilins|V-set domain containing|C2-set domain containing | 1.81e-03 | 15 | 77 | 2 | 458 | |
| GeneFamily | Proteases, serine | 2.45e-03 | 63 | 77 | 3 | 738 | |
| Coexpression | GSE11961_GERMINAL_CENTER_BCELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY40_DN | 2.03e-05 | 199 | 109 | 7 | M9332 | |
| Coexpression | CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP | 2.07e-05 | 455 | 109 | 10 | M17299 | |
| Coexpression | GSE30971_2H_VS_4H_LPS_STIM_MACROPHAGE_WBP7_KO_UP | 2.09e-05 | 200 | 109 | 7 | M8703 | |
| Coexpression | PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_DN | 3.67e-05 | 148 | 109 | 6 | M2186 | |
| Coexpression | PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_DN | 3.96e-05 | 150 | 109 | 6 | MM887 | |
| Coexpression | GSE14699_NAIVE_VS_DELETIONAL_TOLERANCE_CD8_TCELL_UP | 4.27e-05 | 152 | 109 | 6 | M2938 | |
| CoexpressionAtlas | DevelopingKidney_e11.5_ureteric bud_emap-3844_k-means-cluster#5_top-relative-expression-ranked_1000 | MACC1 ANKRD37 TRIM6 ELL3 SLC2A3 CMTM8 EML5 CELA1 BCAR3 ARHGAP8 | 2.63e-06 | 306 | 104 | 10 | gudmap_developingKidney_e11.5_ureteric bud_1000_k5 |
| CoexpressionAtlas | DevelopingKidney_e11.5_ureteric bud_emap-3844_k-means-cluster#3_top-relative-expression-ranked_500 | 4.93e-06 | 193 | 104 | 8 | gudmap_developingKidney_e11.5_ureteric bud_500_k3 | |
| CoexpressionAtlas | DevelopingKidney_e11.5_ureteric bud_emap-3844_k-means-cluster#4_top-relative-expression-ranked_200 | 5.33e-06 | 90 | 104 | 6 | gudmap_developingKidney_e11.5_ureteric bud_200_k4 | |
| CoexpressionAtlas | DevelopingKidney_e11.5_ureteric bud_emap-3844_top-relative-expression-ranked_200 | 1.51e-05 | 162 | 104 | 7 | gudmap_developingKidney_e11.5_ureteric bud_200 | |
| CoexpressionAtlas | DevelopingKidney_e11.5_ureteric bud_emap-3844_top-relative-expression-ranked_500 | 2.78e-05 | 401 | 104 | 10 | gudmap_developingKidney_e11.5_ureteric bud_500 | |
| CoexpressionAtlas | DevelopingKidney_e11.5_ureteric bud_emap-3844_top-relative-expression-ranked_1000 | MACC1 ANKRD37 TMC4 TRIM6 ELL3 ST14 SLC2A3 CMTM8 EML5 CELSR2 CELA1 C1orf159 BCAR3 ARHGAP8 | 4.24e-05 | 813 | 104 | 14 | gudmap_developingKidney_e11.5_ureteric bud_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Medullary collecting duct_emap-28063_k-means-cluster#2_top-relative-expression-ranked_500 | 9.45e-05 | 93 | 104 | 5 | gudmap_developingKidney_e15.5_Medullary collecting duct_500_k2 | |
| ToppCell | PND10-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet-Megakaryocyte/Platelet_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.04e-07 | 178 | 110 | 7 | 9e1f2596fcea5b79cc50b58d83706bb8605e224f | |
| ToppCell | PND10-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.04e-07 | 178 | 110 | 7 | aa659bd283c4dfbe292cd8698bbf6b1999ca3314 | |
| ToppCell | PND10-Immune-Immune_Myeloid-Megakaryocyte/Platelet|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.04e-07 | 178 | 110 | 7 | bf1d273802a4f42e52ea1bd2a0cae2039559c093 | |
| ToppCell | droplet-Heart-HEART-1m-Neuronal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.10e-07 | 186 | 110 | 7 | fddc6b93f98b10aaf8d4ebc142b46d8213f3129d | |
| ToppCell | Influenza_Severe-Neutrophil|Influenza_Severe / Disease group and Cell class | 3.01e-06 | 161 | 110 | 6 | 98c95b1b85d5427415af2ca8fb14849e97f6e8b5 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 3.59e-06 | 166 | 110 | 6 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-hematopoietic_precursor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.37e-06 | 178 | 110 | 6 | 8aef208b6351143562c87715bb11628880abce94 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.49e-06 | 184 | 110 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.49e-06 | 184 | 110 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.49e-06 | 184 | 110 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.90e-06 | 186 | 110 | 6 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | COVID-19_Severe-Myeloid_G-Neutrophil|COVID-19_Severe / Disease group, lineage and cell class | 7.57e-06 | 189 | 110 | 6 | a62f4c445ede00d15b74bee65f4e4fb54cfd4d32 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-Neutrophil|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.57e-06 | 189 | 110 | 6 | f6b2b4824505f0119a017fdb73c55418fb651645 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-Neutrophil|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.57e-06 | 189 | 110 | 6 | db8e314ce95c32542bb4015a77032a33211fea0b | |
| ToppCell | Control-Endothelial-VE_Capillary_B|Endothelial / Disease state, Lineage and Cell class | 7.80e-06 | 190 | 110 | 6 | 7f3f419fffe02934b6f27b697f7a6401072491ed | |
| ToppCell | PSB-critical-LOC-Myeloid-Neutrophil|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.28e-06 | 192 | 110 | 6 | 8dbdaa6a81767a866fb856f99ae35f9ee8064106 | |
| ToppCell | severe-Myeloid-Neutrophils_3|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 8.53e-06 | 193 | 110 | 6 | f4d43dfbf4115dd0f843ea5cf08049220342a047 | |
| ToppCell | Thalamus-Neuronal|Thalamus / BrainAtlas - Mouse McCarroll V32 | 8.53e-06 | 193 | 110 | 6 | 712a4acd1167e43543950bc819ff11984e6f718d | |
| ToppCell | severe-Myeloid-Neutrophils_3|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 8.78e-06 | 194 | 110 | 6 | 1f8edab1c8ba48bc0114429ea47aab378b5830b7 | |
| ToppCell | mild-Myeloid-Neutrophils_1|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 8.78e-06 | 194 | 110 | 6 | ccd911ce3251cd1c60f1fb2ce00650fbe7a379bb | |
| ToppCell | COVID_vent-Myeloid-Monocytic-Neutrophil|COVID_vent / Disease condition, Lineage, Cell class and subclass | 8.78e-06 | 194 | 110 | 6 | eb23b171e429165dd26a64377eae7fa2ce25f547 | |
| ToppCell | mild-Myeloid-Neutrophils_3|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 9.04e-06 | 195 | 110 | 6 | a1cfed0092debcc003eff6a62508556b7664d5e1 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_submucosal-gland-Myoepithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.86e-06 | 198 | 110 | 6 | 24bc53bd8ef8f4f2f4fc377aeee75126ad5d311f | |
| ToppCell | severe-Myeloid-Neutrophils_4|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.01e-05 | 199 | 110 | 6 | 50242666def13e5d4149c563ae000d6768f086f7 | |
| ToppCell | Club-club-7|World / Class top | 1.92e-05 | 64 | 110 | 4 | df413c5328966480479c41826461c4d817fbe33d | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Adora2a-Excitatory_Neuron.Gad1Gad2.Adora2a-Th_(eccentric_SPN,_iSPN-like_markers,_Th+)|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.44e-05 | 68 | 110 | 4 | 10895359ba0a3598edbf27a202e4232bfa483ec1 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Adora2a-Excitatory_Neuron.Gad1Gad2.Adora2a-Th_(eccentric_SPN,_iSPN-like_markers,_Th+)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.44e-05 | 68 | 110 | 4 | 761bb83d0fe2817b8fffe1fea6fe738d8107bbbd | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-Neutrophil-Neu_1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.74e-05 | 142 | 110 | 5 | 191a13bba143ecdfc2bfd797c3ac191481388298 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-Neutrophil-Neu_1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.83e-05 | 143 | 110 | 5 | b405dba9a83a99cc7b53ce71772bc52a0bbb0d4e | |
| ToppCell | P03-Hematopoietic-Immune-immune_cell_unspecified|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.45e-05 | 149 | 110 | 5 | 43d756f81d532b5c7f2306e6af9d072d496cbc8e | |
| ToppCell | P03-Hematopoietic-Immune|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.45e-05 | 149 | 110 | 5 | 1c5a2572741c47246d455c865e8e1677c9f49598 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Epithelial-epithelial_progenitor_cell-Proximal_progenitor|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.56e-05 | 158 | 110 | 5 | 2ae863ccef201414b82a2ecf7cf1bbb1b0ce4a3c | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-3|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 4.56e-05 | 158 | 110 | 5 | ec1a71b8f46179642b5af20e27764bb43c4b8e99 | |
| ToppCell | normal_Pleural_Fluid-T/NK_cells-CD4+_Th|normal_Pleural_Fluid / Location, Cell class and cell subclass | 4.70e-05 | 159 | 110 | 5 | ebd840ac2b07e62086ee7b5bb01c21804a0fdc7b | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.84e-05 | 160 | 110 | 5 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | Entopeduncular-Endothelial-ENDOTHELIAL_STALK|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 4.84e-05 | 160 | 110 | 5 | 04714d0b9bad4c11fa193ed168e2d84a4df39e2e | |
| ToppCell | Healthy/Control-CD8+_T_naive|Healthy/Control / Disease group and Cell class | 4.84e-05 | 160 | 110 | 5 | e1386c21fcbbf57fa32d8bdfba3cb1887477ff73 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.84e-05 | 160 | 110 | 5 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | 15-Distal-Immune-Immune|Distal / Age, Tissue, Lineage and Cell class | 5.13e-05 | 162 | 110 | 5 | e190c496ed1e206b86566edfee23c99a99fe90d0 | |
| ToppCell | Influenza_Severe-Neutrophil|World / Disease group and Cell class | 6.27e-05 | 169 | 110 | 5 | 6e8e2580e19c96bcf7fa6a6d8c183df65f428396 | |
| ToppCell | wk_15-18-Hematologic-Meg-ery-Megakaryocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 6.27e-05 | 169 | 110 | 5 | d571e84e01e3316748d4407ed98881b17484e035 | |
| ToppCell | severe_COVID-19-Neutrophil|World / disease group, cell group and cell class (v2) | 6.45e-05 | 170 | 110 | 5 | dfc807e0dd66179490a258ecbe8eb439e715799d | |
| ToppCell | wk_20-22-Hematologic-Meg-ery-Megakaryocyte|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 6.45e-05 | 170 | 110 | 5 | eace4dd09cdbde0fa40a6aa0f3dba1114d0ce475 | |
| ToppCell | CTRL-Myeloid-Neutrophil|Myeloid / Disease state, Lineage and Cell class | 6.45e-05 | 170 | 110 | 5 | 151dabe1d240dde414c881bf4fa816c69fa1c32d | |
| ToppCell | ileum|World / shred on tissue and cell subclass | 6.45e-05 | 170 | 110 | 5 | 9f1211bd4287620e19a59f21e6ecdca3e42e0260 | |
| ToppCell | facs-Heart-RA-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.63e-05 | 171 | 110 | 5 | b54d9d6b03c9c6f28a71cf2ed2bfa9a335bba949 | |
| ToppCell | facs-Heart-RA-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.63e-05 | 171 | 110 | 5 | 9d825a2e799421af4f2cf4f4dc8e239b5d00476d | |
| ToppCell | PND03-Immune-Immune_Myeloid-Megakaryocyte/Platelet|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.82e-05 | 172 | 110 | 5 | e39ea2f4edbf36ebf9604fa6f9349081859c596c | |
| ToppCell | PND03-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.82e-05 | 172 | 110 | 5 | 875ea290840e835952623b905eb610f3c71456d2 | |
| ToppCell | CTRL-Myeloid-Neutrophil|CTRL / Disease state, Lineage and Cell class | 6.82e-05 | 172 | 110 | 5 | ef3a6fe3b7300959f9f71130200c7fb8741c42b0 | |
| ToppCell | PND03-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet-Megakaryocyte/Platelet_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.82e-05 | 172 | 110 | 5 | bcc50bed47465daa953ba91f17d1ee4c947ab461 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Basal_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 6.82e-05 | 172 | 110 | 5 | b66dbfff5e4f53ca8ece91ff9c5dc66a71f07c63 | |
| ToppCell | severe_influenza-Neutrophil|severe_influenza / disease group, cell group and cell class (v2) | 7.01e-05 | 173 | 110 | 5 | 615e266419b9f06e964eff73cb466f05451ba0dd | |
| ToppCell | severe_influenza-Neutrophil|World / disease group, cell group and cell class (v2) | 7.20e-05 | 174 | 110 | 5 | f9f07436b7d3f190800cd85d229f007032f391e1 | |
| ToppCell | PND07-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet-Megakaryocyte/Platelet_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.20e-05 | 174 | 110 | 5 | a3f4981b10afa9d41a1c66c7f98522a8a534f82b | |
| ToppCell | PND07-Immune-Immune_Myeloid-Megakaryocyte/Platelet|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.20e-05 | 174 | 110 | 5 | 6cc108dde4b3f98a78a6040280f0d5e4aaa5bd75 | |
| ToppCell | PND07-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.20e-05 | 174 | 110 | 5 | 4b8bc5568e36031c8ecf001bb646809038c23919 | |
| ToppCell | CV-Healthy-4|Healthy / Virus stimulation, Condition and Cluster | 7.20e-05 | 174 | 110 | 5 | 26544cc5f51cb4dc1251e62d9f80b6c956194d38 | |
| ToppCell | CF-Myeloid-Neutrophil|Myeloid / Disease state, Lineage and Cell class | 7.40e-05 | 175 | 110 | 5 | 8020c3a34f77e68e8149f87481fb1dddd2ac675e | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Hematopoietic-Myeloid-Megakaryocyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.40e-05 | 175 | 110 | 5 | b85279b9efd72d7074c4226d50ce139a38c0e1c1 | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.81e-05 | 177 | 110 | 5 | 84591e28482ab62a5ef41e61043eb64912766356 | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet-Megakaryocyte/Platelet_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.81e-05 | 177 | 110 | 5 | 4bc100062891d07cacd10ffba38966cc6302c92f | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.81e-05 | 177 | 110 | 5 | 9f3a2adb9cd4f0a059afc87b6e377a9702154bb1 | |
| ToppCell | facs-Spleen-nan-3m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.81e-05 | 177 | 110 | 5 | ac0cf03e2a1baf84db3ae245d59bbc6ae52c13be | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Endothelial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.02e-05 | 178 | 110 | 5 | f2002a5c4758d0af6c1880ca12f0af0d5e8888e4 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.02e-05 | 178 | 110 | 5 | fcbbcc44271515de1969b4732b6441c012693d5f | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic-Neutrophil-Neu_c4-RSAD2|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.02e-05 | 178 | 110 | 5 | 94a86f5232fffa6a92a30ea21fb44eec33b4d6c8 | |
| ToppCell | wk_15-18-Mesenchymal-Mesothelial-intermediate_mesothelial|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 8.23e-05 | 179 | 110 | 5 | b1f085e4c8d65d5cdbfaf2db80343638abb08979 | |
| ToppCell | droplet-Heart-4Chambers-21m-Mesenchymal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.23e-05 | 179 | 110 | 5 | b44e2d53b82c3c141bfc6539054b19708200a0d9 | |
| ToppCell | COVID-19_Severe-Neutrophil-|COVID-19_Severe / Disease condition and Cell class | 8.67e-05 | 181 | 110 | 5 | 5e5101195d5ff8c8ea7ddcf0bc4f4e03e64c01e0 | |
| ToppCell | COVID-19_Severe-Neutrophil|COVID-19_Severe / Disease condition and Cell class | 8.67e-05 | 181 | 110 | 5 | aa5e5fb0308b5e2ef918548c85529c9a433c57f5 | |
| ToppCell | RA-07._Pericyte|World / Chamber and Cluster_Paper | 8.90e-05 | 182 | 110 | 5 | 2075efeae633550fb2eb026d0dfd741c8252482e | |
| ToppCell | severe-Myeloid-Neutrophils_1|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 9.13e-05 | 183 | 110 | 5 | 60a6112aa4fc4f5debda4c7e81b37539ba2e4e6e | |
| ToppCell | droplet-Lung-30m-Hematologic-lymphocytic-plasma_cell-plasma_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.13e-05 | 183 | 110 | 5 | 0f6799e4f058bed546fe5759502430f4a19635da | |
| ToppCell | LA-07._Pericyte|World / Chamber and Cluster_Paper | 9.13e-05 | 183 | 110 | 5 | e3835db4795362b0442d5893baf2a78efcc20428 | |
| ToppCell | 10x5'-bone_marrow-Hematopoietic_Erythro-Mega-Megakaryocyte_early|bone_marrow / Manually curated celltypes from each tissue | 9.13e-05 | 183 | 110 | 5 | 3cc9f3dc3bc4bde1d3408b0a6ba58e135a11036d | |
| ToppCell | LV-07._Pericyte|World / Chamber and Cluster_Paper | 9.13e-05 | 183 | 110 | 5 | 273db6a3b00a93ca852498471187b642b5368185 | |
| ToppCell | droplet-Lung-30m-Hematologic-lymphocytic-plasma_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.13e-05 | 183 | 110 | 5 | 8ef5223e46f1fd81a856261248cc77e7c7e72ef6 | |
| ToppCell | CF-Myeloid-Neutrophil|CF / Disease state, Lineage and Cell class | 9.13e-05 | 183 | 110 | 5 | da43827952e6fdee2ce94648c316182f272b321c | |
| ToppCell | 10x3'2.3-week_12-13-Myeloid_neutrophil-granulo-eo/baso/mast-basophil|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 9.13e-05 | 183 | 110 | 5 | f9a3af96c0fb7d5c4d7df6db8b2c42e322418c08 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-fibroblastic-Stromal_4_(MMP1+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.13e-05 | 183 | 110 | 5 | 269afec240a756eec3bbae5f30ec784281af3433 | |
| ToppCell | COPD-Myeloid-cMonocyte|World / Disease state, Lineage and Cell class | 9.37e-05 | 184 | 110 | 5 | ceec41ed5636032aaf7716d1203816ea58bd39bd | |
| ToppCell | COVID_non-vent-Myeloid-Monocytic-Neutrophil|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 9.61e-05 | 185 | 110 | 5 | 2c89af7cdf5306b900a5b8ec4fdfb8210e5667ed | |
| ToppCell | LV-07._Pericyte|LV / Chamber and Cluster_Paper | 9.61e-05 | 185 | 110 | 5 | acb38eba871ec72f2a8136a33b87d33b8c85465d | |
| ToppCell | Influenza-Influenza_Severe-Myeloid-Neutrophil|Influenza_Severe / Disease, condition lineage and cell class | 9.86e-05 | 186 | 110 | 5 | 1dfcec9196d4db76fba3abc74e85885b1fb98b87 | |
| ToppCell | CF|World / Disease state, Lineage and Cell class | 1.01e-04 | 187 | 110 | 5 | eec4d4e4a658e3a61c05745167a1a5e3d39bb43e | |
| ToppCell | E12.5-Epithelial|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.01e-04 | 187 | 110 | 5 | 29ea5e14dac3321df76f6aa4f053068b49c4a4bf | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.04e-04 | 188 | 110 | 5 | aa46073e2940dc1d2020b2e259bf0fc06cb990ee | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.04e-04 | 188 | 110 | 5 | 04814b78da936a51a497e23060d19ca0d619e250 | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Treg_cell_3|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.06e-04 | 189 | 110 | 5 | 99b01893da9f9f7c9528afaffad178285211738b | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.09e-04 | 190 | 110 | 5 | 55df73c8b696967a925b1772631f6900eff0fa30 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.5.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.09e-04 | 190 | 110 | 5 | ce049630ed69d31f00acbc1b5b0896efc592121f | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.09e-04 | 190 | 110 | 5 | 494fbab37305a7f92cddec75b291d42282555f5f | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.09e-04 | 190 | 110 | 5 | b2bd2cb384bb8a5662064ed1aee68e905e1f780d | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Monocytic-Classical_Monocyte-Mono_c1-CD14-CCL3|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.09e-04 | 190 | 110 | 5 | 212f0d9defcc3174e225cc3d90e7814e238794b6 | |
| ToppCell | COVID-19-Heart-T_cell|Heart / Disease (COVID-19 only), tissue and cell type | 1.09e-04 | 190 | 110 | 5 | e6c3a6e01fef6c5b49f72661d4fb0414ba9046bf | |
| ToppCell | control-Myeloid-Neutrophils_1|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.12e-04 | 191 | 110 | 5 | db1b3cd07d7d190155b2d14e82e1d124975fbd0b | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.12e-04 | 191 | 110 | 5 | 6e1d00404d795ec7cf60f685e42e4ad9a16ac596 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.12e-04 | 191 | 110 | 5 | cd709bbcd320373468ea7f058ee5fda8a067b5d0 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.12e-04 | 191 | 110 | 5 | f158e393976b685b896a41871bda1ab65a8b58f5 | |
| Disease | triacylglycerol 52:2 measurement | 4.83e-05 | 55 | 107 | 4 | EFO_0010414 | |
| Disease | autosomal recessive intellectual developmental disorder (implicated_via_orthology) | 3.60e-04 | 8 | 107 | 2 | DOID:0060308 (implicated_via_orthology) | |
| Disease | triacylglycerol 50:3 measurement | 3.85e-04 | 39 | 107 | 3 | EFO_0010410 | |
| Disease | pancreatitis (implicated_via_orthology) | 4.61e-04 | 9 | 107 | 2 | DOID:4989 (implicated_via_orthology) | |
| Disease | microphthalmia (implicated_via_orthology) | 8.40e-04 | 12 | 107 | 2 | DOID:10629 (implicated_via_orthology) | |
| Disease | cataract (biomarker_via_orthology) | 9.90e-04 | 13 | 107 | 2 | DOID:83 (biomarker_via_orthology) | |
| Disease | triacylglycerol 46:2 measurement | 1.15e-03 | 14 | 107 | 2 | EFO_0010402 | |
| Disease | triacylglycerol 48:1 measurement | 1.71e-03 | 17 | 107 | 2 | EFO_0010404 | |
| Disease | triacylglycerol 46:1 measurement | 2.37e-03 | 20 | 107 | 2 | EFO_0010401 | |
| Disease | asthma (is_implicated_in) | 2.60e-03 | 157 | 107 | 4 | DOID:2841 (is_implicated_in) | |
| Disease | hepatitis B (is_marker_for) | 2.62e-03 | 21 | 107 | 2 | DOID:2043 (is_marker_for) | |
| Disease | triacylglycerol 48:2 measurement | 2.87e-03 | 22 | 107 | 2 | EFO_0010405 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LWSAGLLCSQVPAAF | 71 | P20292 | |
| LACGLPFWAITISNN | 106 | P30411 | |
| QLLCLSSGWFPQPTA | 151 | Q6UXE8 | |
| SNVSGALCISQAWPG | 491 | Q9NUB1 | |
| GPLLCRGDQSFWNSA | 781 | Q9BZ76 | |
| PGPGWSCLFSFIVSQ | 61 | Q9HB65 | |
| FSQRPWSALAGQACS | 486 | A0A096LP49 | |
| AILTCIVSPGNGASW | 181 | Q96PZ7 | |
| PERTCLLNGSWSGLQ | 2956 | Q96PZ7 | |
| LLNGSWSGLQPVCEA | 2961 | Q96PZ7 | |
| QLLCQSSGWFPRPTA | 151 | Q6UX41 | |
| SSPGNFVLTCQWKNL | 181 | O75815 | |
| LQFCGWPTGVVTSNI | 1631 | Q9UIF8 | |
| QVSVSRGPCNWFLFS | 1686 | Q5H9F3 | |
| GPLLCQGDRSFWNSA | 781 | Q9C0A0 | |
| SGKLSESPGCFWNSL | 121 | Q8N1L1 | |
| SQSSGLRGLWDCLPA | 696 | Q8N283 | |
| LLSNPTSGCSWLFQP | 46 | P01732 | |
| TSGCSWLFQPRGAAA | 51 | P01732 | |
| GWLPPNLFNCTSITF | 2016 | Q9HCU4 | |
| SQLGDLSSWCNGLLQ | 1231 | O14525 | |
| SGLACFLLWQLQTGA | 41 | Q7Z713 | |
| FAGWLCSTIGLNQPS | 371 | Q02750 | |
| GWNGLLVLKNSCFPT | 721 | Q8NDT2 | |
| QLSYNAGALTWLSCG | 106 | Q99732 | |
| QSFWGSEAALLLVCP | 171 | Q5SQ64 | |
| PFWLLSSACALAQAG | 401 | Q6IWH7 | |
| SGLALLGTPWPFNCN | 551 | Q9BY79 | |
| IGLSCGDPQFSLWAI | 186 | Q8NGE0 | |
| FLQFLQGTGCPSESW | 381 | Q9BZJ8 | |
| LGCFSAGLPKTEANW | 36 | P40933 | |
| QSSGLRFSGCPELWQ | 371 | Q0VG99 | |
| LGCWNPVTGLNGSLT | 416 | O43424 | |
| CSLIFPATTWISGGQ | 756 | O60486 | |
| GSTCDLNLKIPGNWF | 2151 | Q14315 | |
| GSVGNLYSWQILTCL | 1621 | Q9HD67 | |
| CRGTLQGLVSWGTFP | 211 | P49862 | |
| ALAGPWANICAGKSS | 16 | O14960 | |
| GAILANNSPCYITGW | 136 | Q9UNI1 | |
| LSGVNVPGNASSGWC | 231 | Q15717 | |
| CLNWLDAQSGLASAP | 46 | Q96FE7 | |
| SGGPLTCLQSGSWVL | 231 | Q8NF86 | |
| CSNWTSNFLVGLLFP | 431 | Q8TDB8 | |
| GLCSSWLASLDPGQG | 416 | Q9UHB4 | |
| LKFISQWCGGLPSTS | 1731 | Q9UG01 | |
| TSEALPLCWQGGFQP | 616 | Q86Y26 | |
| ANPWNTIALLCGAFL | 301 | Q9H813 | |
| AGPCSLSQGNLSPNW | 766 | O43182 | |
| LGSLCLDTNQAPNWT | 11 | Q2TBC4 | |
| QGSLPLLGQCLTSYW | 976 | Q8N0W3 | |
| GSQAVWSLSSCKPGF | 26 | Q9UM13 | |
| VGPSAAQTLRSFCAW | 281 | O75173 | |
| LNWIPCGQSFFGPTL | 161 | Q9NXB9 | |
| GCRPLGQLDSFSWAA | 146 | Q5U4N7 | |
| QASWACNLILGAPDS | 81 | P14784 | |
| NFAGPSWDCVLQGAL | 71 | Q5UAW9 | |
| SCLDLNTISQSPGWA | 191 | Q6ZN28 | |
| TSPALFNRCVLNWFG | 3081 | Q14204 | |
| SFSGLQAPLNDPWAC | 376 | Q6ZS86 | |
| GCSNWTSNFLVGLLF | 406 | P11169 | |
| GFCWLSPALQDLQAT | 36 | Q86W47 | |
| NCTAWNSFGPGTAII | 471 | Q96J84 | |
| WLCFPISLGSQASGG | 16 | O60383 | |
| FWSLCGNALTPKRGV | 176 | Q05BV3 | |
| QSSGNSSCRIPLWGF | 201 | Q96HA4 | |
| SALWGLFCNGSQPSA | 336 | Q9Y666 | |
| LFSPGAVALCSEWLQ | 651 | Q8NAC3 | |
| EGSWAQCPVFLQTLA | 1001 | O75334 | |
| TWQQSPFCLGSGRPQ | 396 | A6NGG8 | |
| SPGDAQQWGCLQLSL | 111 | Q8NBV8 | |
| IWASGCGSLQLVFSP | 1246 | Q93008 | |
| TDLCIPNSGSGWLGS | 181 | Q496J9 | |
| FLLNAVGWLCSSPGA | 76 | Q9Y4C2 | |
| LSGQQLPCRSTLTWG | 386 | P57071 | |
| RPALGSSVALNCTAW | 21 | Q6IA17 | |
| NLFTPGQLLKTWCGS | 211 | Q9Y2K2 | |
| SWNTGNGSPDAICFS | 1736 | O75592 | |
| SECLSPPGGSDNLWN | 746 | Q8IZU2 | |
| WSFLGPVCAIFSANL | 506 | Q9BY15 | |
| LWAANGLPNPFCSSD | 641 | Q9UNK9 | |
| FLAWNPAGTLLASCG | 21 | O76071 | |
| VAWAPSGNLLATCSR | 111 | O76071 | |
| LTSFDNTGNVCIWPS | 116 | Q7Z624 | |
| QVPWTTVGLCFNGSA | 101 | Q8IZV2 | |
| FICAWNPVSDLLASG | 236 | O60907 | |
| NECGLVPSALLTFSW | 396 | Q9BZV1 | |
| NAPLCSTFLGAPTLW | 226 | Q96MN9 | |
| QNSWLCGSLVVPSGG | 761 | Q2QGD7 | |
| CLNLATGQWTALPGQ | 371 | C9JR72 | |
| WLIPQTSFLSNVCGL | 176 | Q6NTF9 | |
| SKLCGPFRGQSSIWA | 616 | Q7Z404 | |
| CGASLISPNWLVSAA | 641 | Q9Y5Y6 | |
| CLSFNPLTSLLQWGG | 491 | Q12772 | |
| GNPLDNGWTLSCSLP | 391 | Q68DE3 | |
| AGLSWNSLGPAATSQ | 266 | Q9UJT2 | |
| NGLSGNTTIPFSSCW | 4136 | Q86WI1 | |
| CLISGLQPGNSYWLQ | 241 | P40238 | |
| PVGLKNVGNTCWFSA | 161 | Q96RU2 | |
| SNLACVFGLNLIWPS | 371 | P85298 | |
| LCALWQGSQTAFSPE | 226 | Q9Y6I4 | |
| PAALCGLVWTANFVA | 116 | Q6ZT12 | |
| CTWLPALLVGANTFA | 931 | Q8TEQ8 | |
| LWGLGTLQQESCPGN | 441 | Q8WUA4 | |
| WIFSNPDGVCTAGNS | 246 | O60806 | |
| SCPRNWLGFTLLTSG | 216 | Q9Y334 | |
| TSAGYGVNLIWSCPQ | 676 | Q9HD43 | |
| QLLCRQGSWSVFPPG | 1246 | P01266 | |
| YSLLCSGPSENGQTW | 246 | Q9Y4E6 | |
| TWPCILGLQSFSSGR | 331 | Q8NG06 | |
| AWILGVCSNSLGPTF | 366 | Q9C030 | |
| SQFGIWFLVSLCTPS | 501 | Q9P2D8 | |
| NSTLTWQQYGALCGP | 661 | O76024 | |
| ICLGASNPPWASTLF | 146 | A8MZ59 | |
| CNLNGTLAPATWQGA | 296 | Q9UQQ1 |